Global Generic Drugs Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global generic drugs market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the route of administration, application, end user, and region. The global market for generic drugs can be segmented by route of administration: injectable, oral, topical, others. The oral segment is estimated to account for the largest share of the global generic drugs market. Generic drugs market is further segmented by application: anti-cancer drugs, anti-infectives, cardiovascular products, central nervous system (CNS) drugs, drugs for arthritis, respiratory products, others. The cardiovascular products segment held the largest revenue share in 2022. Based on end user, the generic drugs market is segmented into: hospitals and clinics, retail pharmacies, others. Globally, the retail pharmacies segment made up the largest share of the generic drugs market. On the basis of region, the generic drugs market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Asia-Pacific was the largest contributor to the global generic drugs market in 2022.
Market Segmentation
By route of administration: injectable, oral, topical, others
By application: anti-cancer drugs, anti-infectives, cardiovascular products, central nervous system (CNS) drugs, drugs for arthritis, respiratory products, others
By end user: hospitals and clinics, retail pharmacies, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report has also analysed the competitive landscape of the global generic drugs market with some of the key players being Aspen Pharmacare Holdings Limited, Abbott Laboratories, AbbVie Inc., Aurobindo Pharma Limited, Baxter International Inc., Cipla Limited, Eli Lilly and Company, Fresenius Kabi AB, GlaxoSmithKline plc, Hikma Pharmaceuticals plc, Lupin Limited, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global generic drugs market.
To classify and forecast the global generic drugs market based on route of administration, application, end user, region.
To identify drivers and challenges for the global generic drugs market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global generic drugs market.
To identify and analyze the profile of leading players operating in the global generic drugs market.
Why Choose This Report
Gain a reliable outlook of the global generic drugs market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION
Injectable
Oral
Topical
Others
PART 6. MARKET BREAKDOWN BY APPLICATION
Anti-cancer drugs
Anti-infectives
Cardiovascular products
Central nervous system (CNS) drugs
Drugs for arthritis
Respiratory products
Others
PART 7. MARKET BREAKDOWN BY END USER
Hospitals and clinics
Retail pharmacies
Others
PART 8. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 9. KEY COMPANIES
Aspen Pharmacare Holdings Limited
Abbott Laboratories
AbbVie Inc.
Aurobindo Pharma Limited
Baxter International Inc.
Cipla Limited
Eli Lilly and Company
Fresenius Kabi AB
GlaxoSmithKline plc
Hikma Pharmaceuticals plc
Lupin Limited
Mylan N.V.
Novartis AG
Pfizer Inc.
Sanofi S.A.
STADA Arzneimittel AG
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
2024 Global Infectious Disease Molecular Diagnostics Market
2024 Global Infectious Disease Molecular Diagnostics Market for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation ReviewThe report is available by country, section, market segment, individual test,
USD 17500 View ReportGlobal Microalbumin Database and Analysis
Global Microalbumin Database and AnalysisThis new report provides analysis of Bilirubin Direct testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by
USD 850 View ReportGlobal Generic Drugs Market Research Report 2023-2027
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Generic Drugs Report by Material, Application, and Geography Global Forecast
USD 3200 View Report2021 Generic Drugs: Leading Companies Capabilities, Goals and Strategies
This report is part of the Competitive Analysis Series prepared by to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to
USD 3500 View ReportFill The Form For Sample Request